I. Martins

发表

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia

H. Paulson, Haibin Xia, Q. Mao, 2004, Nature Medicine.

Functional Correction of CNS Phenotypes in a Lysosomal Storage Disease Model Using Adeno-Associated Virus Type 4 Vectors

I. Martins, B. Davidson, J. Chiorini, 2005, The Journal of Neuroscience.

Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo

I. Martins, B. Davidson, N. Keiser, 2014, Molecular therapy. Nucleic acids.

Long‐term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)‐deficient mice by adenovirus‐mediated LDLR gene transfer combined with CD154 blockade

I. Martins, B. Davidson, C. Stein, 2000, The journal of gene medicine.

In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors.

I. Martins, B. Davidson, P. McCray, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.

I. Martins, B. Davidson, J. Stokes, 2010, American journal of physiology. Cell physiology.

Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo.

I. Martins, B. Davidson, R. Boudreau, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Systemic Hyperosmolality Improves β-Glucuronidase Distribution and Pathology in Murine MPS VII Brain Following Intraventricular Gene Transfer

I. Martins, B. Davidson, C. Stein, 1999, Experimental Neurology.

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

I. Martins, R. Kotin, B. Davidson, 2000, Proceedings of the National Academy of Sciences of the United States of America.

In Vivo Gene Transfer Using a Nonprimate Lentiviral Vector Pseudotyped with Ross River Virus Glycoproteins

I. Martins, B. Davidson, D. A. Sanders, 2002, Journal of Virology.

RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.

H. Paulson, Q. Mao, S. Eliason, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Identification of PDGFR as a receptor for AAV-5 transduction

Giovanni Di Pasquale, D. Scudiero, A. Monks, 2003, Nature Medicine.

Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNS.

I. Martins, B. Davidson, J. Chiorini, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

The lymphocytic choriomeningitis virus envelope glycoprotein targets lentiviral gene transfer vector to neural progenitors in the murine brain.

I. Martins, B. Davidson, C. Stein, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.

I. Martins, B. Davidson, J. McBride, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

717. RNAi Therapy for Dominant Neurodegenerative Diseases

H. Zoghbi, H. Paulson, Haibin Xia, 2004 .

Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS

I. Martins, B. Davidson, J. Chiorini, 2005, Gene Therapy.

Tissue Spectroscopy and Optical Clearing of Colorectal Mucosa in the Pursuit of New Cancer Diagnostic Approaches

I. Martins, R. Henrique, I. Carneiro, 2021, Journal of Biomedical Photonics & Engineering.

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

I. Martins, R. Kotin, B. Davidson, 2000, Proceedings of the National Academy of Sciences of the United States of America.